US 11512141
Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11512141 (Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment) held by The Board of Regents of the University of Texas System expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/437, A61K31/505